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A Peptide/MHCII conformer generated
in the presence of exchange peptide is
substrate for HLA-DM editing
Andrea Ferrante* & Jack Gorski
Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53201.
The mechanism of HLA-DM (DM) activity is still unclear. We have shown that DM-mediated peptide
releasefromHLA-DR(DR)isdependentonthepresenceofexchangepeptide.However,DMalsopromotes
a small amount of peptide release in the absence of exchange peptide. Here we show that SDS-PAGE
separates purified peptide/DR1 complexes (pDR1) into two conformers whose ratio is peptide
Kd-dependent. In the absence of exchange peptide, DM only releases peptide from the slower migrating
conformer. Addition of exchange peptide converts the DM-resistant conformer to the slower migrating
conformer, which is DM labile. Thus, exchange peptide generates a conformer of pDR1 which constitutes
the intermediateforpeptideexchange andthesubstrate forDMactivity.Theresolutionofthe intermediate
favorsthehighestaffinitypeptide.However,oncefoldedintotheDM-resistantconformer,evenlowaffinity
peptides can be presented in the absence of free peptide, broadening the repertoire available for
presentation.
T
he recognition of pathogen-derived peptides by CD41 T cells is a crucial event in the initiation of an
immune response. These peptides are presented in the context of class II MHC (MHCII) on antigen-
presentingcells(APC).Antigenpresentationisamultistepprocessinvolvingtheintracellularfragmentation
of protein antigens, followed by binding of the derived peptide epitopes to MHCII molecules with the participa-
tion of the peptide-editing molecule HLA-DM (DM), and subsequent transport to the APC surface
1. The
MHCII–peptide–DM interaction is a key step in the selection of epitopes. However, the details of this process
are still poorly understood and this impediment is reflected in the difficulty in approaching rational vaccine
design or in epitope prediction
2.
Using HLA-DR1 as our test system, we have shown that peptide binding is a distributive process in that all
peptide residuescan synergisticallycontributebinding energy.We haveobserved that within a certain range ofKd,
peptide binding is highly cooperative. We interpret cooperativity as evidence of the folding process involving both
peptideandMHCIIthatresultsinastablecomplex
3,4.Morerecently,wehaveobservedthat:1)intheabsenceofan
exchangepeptide,thepeptide-editingfactorDMwillreleasepreboundpeptideverypoorly;2)inthepresenceofan
exchange peptide, DM-promoted release of the prebound peptide does not show cooperativity, indicating that the
typical unfolding associated with peptide release does not happen; and 3) if the exchange peptide is of a lower
affinity than the prebound peptide, exchange does not take place, even with excess exchange peptide
5.
WehaveproposedthattheoutcomeofepitopeselectioninthepresenceofDMmaybeconsideredtheresultof
a ‘‘compare-exchange’’ mechanism involving the continuous formation of a metastable intermediate generated
by the two peptides, DR and DM. DM would bind this intermediate, release the prebound peptide while putting
MHCII molecule in an ‘‘exchangeable’’ conformer whose geometry allows for rebinding of the prebound peptide
inthecasethattheexchangepeptidedoesnotsucceedinfoldingintothebindinggroove
5,6.Thepossibilityofsuch
an intermediate was also postulated for peptide exchange in the absence of DM
7,8.
An important question in describing DM activity is whether the peptide/MHCII (pMHCII) complex needs to
assume aspecificconformation tobetargetedbyDM.Pastreportshaveproposedthattheconformationinduced
by an empty/flexible hydrophobic pocket 1 of DR1 is what DM recognizes
9,10. Recent work has shown that DM
would bind to DR conformers in which this critical part of the binding site is already vacant
11.
Our compare exchange model presupposes that the presence of an exchange peptide is ‘‘sensed’’ by DM. Our
observation of a small but measurable peptide release by DM in the absence of exchange peptide together with
these previous reports suggests the hypothesis that two forms of the bound complex coexist, with one being the
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case. Newly generated pMHCII complexes show two conformers on
thebasisofgelmigration,withtheslowermigratingconformerbeing
DM-sensitive. The level of the DM-labile conformer is a function of
thepeptideKd.DM-labileconformercanbegeneratedfromtheDM-
resistant conformer by addition of an exchange peptide. We propose
a more refined model of DM activity and the implications of this
model are discussed in the context of epitope selection.
Results
pMHCII complexes are separated in two bands by SDS-PAGE
under non-reducing conditions whose ratio is peptide affinity
dependent. We have previously shown that in addition to strong
DM activity in the presence of an exchange peptide, a small
amount of DM activity can be observed in the absence of exchange
peptide
5. The interaction of peptides with MHCII molecules is
cooperative, and we interpreted cooperativity as evidence for
peptide binding as flexible process
3,4. Flexibility during a ligand/
receptor interaction has been indicated as the structural basis for
the presence of multiple conformers for the same complex
12 and
multiple conformers of MHCII have indeed been reported
9,13,14.I n
order to explain the exchange-peptide-independent activity of DM,
wehypothesizedthat:thepeptide/MHCIIcomplexassumesdifferent
conformers; only one of these conformers constitutes a viable DM
target; and if this conformer exists in the absence of an exchange
peptide, DM will act on it. The first step in addressing this issue is to
study MHCII conformers. We formed pMHCII complexes by
incubating DR1 with three different HA306–319-derived substituted
peptidesofdecreasingaffinity.Thepeptidesadoptedforthisanalysis
and relative Kd values are listed in Table I. The existence of multiple
conformers was analyzed in SDS-PAGE under non-reducing
conditions
15. As shown in Figure 1A, two bands could be identified
in each lane by visualizing the fluorescence from the bound peptide,
with the slower migrating band (top arrow) showing different
intensities. This finding is expected from the literature, and the
slower migrating form has been called ‘‘floppy’’ and the faster
migrating form ‘‘compact’’
15,16.
Therelationbetweenthefractionoftheslowermigratingformand
the affinity of the peptide is shown in Figure 1B. Even though our
analysis is based only on three peptides, the Pearson’s coefficient
indicates a strong linear correlation between peptide Kd and the
amount of the slower migrating conformer, at least for the range of
peptide affinity here considered.
DM promotes release of peptides from the slower migrating
conformer in the absence of an exchange peptide. To investigate
the relation between peptide/DR1 (pDR1) complex conformers and
DM-mediated peptide release in the absence of an exchange peptide,
wemonitored peptide release from100 nMof purified FAM-labeled
pDR1 complexes in the presence of 300 nM of DM and in the
absence of an exchange peptide (Figure 1C). The extent of release
was associated with the Kd of the complexes. We analyzed pre- and
post-DMincubationsamplesinanon-reducingSDSgel(Figure1D).
Clearly,onlythefastermigratingconformerwasdetectablewhenthe
DM-reactionreachedplateau,regardlessofthenatureofthepeptide.
Thus, DM seemed to affect only the slower migrating conformer
(Figure 1D). Therefore we identify the slower migrating conformer
as DM-labile (L) and the faster as DM-stable (S).
Analternativeexplanationforthereducedreleaseofpeptidesfrom
MHCII in the presence of DM and in the absence of exchange pep-
tide might be the formation of an equilibrium between peptide dis-
sociation and re-association. In our experiments, the initial complex
concentration is very low, reducing the probability of re-assocation
by simple Brownian motion in solution. However, we directly tested
this possibility by measuring the stability of the HASG/DR complex
at 100 nM in the presence of DM without exchange peptide.
Simultaneously, we measured the DM-mediated association of
HASG to an equimolar amount of DR at the same concentration.
We reasoned that if the reduced release of peptides from MHCII is
due to rebinding of freshly dissociated peptides, we should reach the
same equilibrium when allowing 100 nM of peptide to bind 100 nM
of DR in the presence of DM in an association assay. As shown in
Supplementary Fig. S1, and consistent with the off-rate shown in
Figure 1C, DM-mediated peptide release in the absence of any unla-
beled peptide reaches an equilibrium at 82% of bound peptide. On
the contrary, during aloading assay, the fraction of bound peptide at
the steady state is about 20%. The significant difference between
peptide release and peptide binding at equilibrium indicates that
the plateau established during a peptide off rate cannot be explained
simply as a cycle of release and rebinding.
Exchange peptide is required for DM to promote release of
prebound peptide from the faster migrating conformer. Having
shown that DM can act on the L-conformer in the absence of
exchange peptide, we wished to investigate the relation between
the S conformer, the exchange peptide, and DM. To this aim, we
enriched the S conformer of the HASG/DR1 complex by treatment
withDM(Figure2A,phaseI). Whentheinitialrelease hadreached a
plateau, DM was purified away from the pDR1 complex by anti-
FLAG affinity chromatography and unbound peptide by filtration
throughacentrifugalfilterdevice. A newrelease reaction wasstarted
by adding fresh DM in the absence of any exchange peptide
(Figure 2A phase II). No further peptide release was detected,
indicating that DM could not act on the S conformer. Non-
reducing SDS-gel analysis showed only the S conformer
(Figure 2B). This suggests that, at least for the time of our
observation, the S-conformer did not spontaneously convert into
the L. The scan of the gel shows the disappearance of the L and the
stability of S conformers (Figure 2C). As expected, the addition of
exchange peptide (unlabeled HASG) to the reaction resulted in the
release of prebound peptide (Figure 2A phase III). This result
indicates that only in the presence of an exchange peptide is the S
conformer a target of DM activity.
Exchange peptide generates a slowly migrating pMHCII confor-
mer. We have shown that the L-conformer is the target of DM in the
absenceofexchangepeptideandthatDMrequiresthepresenceofan
exchange peptide to act on the S-conformer. Thus, we hypothesized
that the exchange peptide converts complexes from S to L
conformers as the simplest way to combine these two observations.
We approached this issue by generating the S conformer of HASG/
DR1byDMtreatment,isolatingthecomplex,andincubatingwithan
equimolar concentration of unlabeled exchange peptide in the
absence of DM. Three peptides with decreasing affinity (HA,
HASG, HASDPG) were used in separate reactions to probe for any
correlationbetweenthenatureoftheexchangepeptideandtheeffect
on the complex. The sequence and affinity values of the unlabeled
peptides are listed in Table I. In Figure 3, peptide off-rates in the
Table I | Dissociation constant values of the peptides used in this
study.Peptideaffinity forDR1wasmeasuredbyequilibrium-based
competitive binding assay as indicated in the Methods. Substi-
tutions are marked in red; amino acid position within peptide
sequenceisindicatedaccordingtothePnumberingsystem,assum-
ing the Y308 as P1
Name Peptide Sequence Kd (nM)
HA306–319 PKYVKQNTLKLAT 73.4 6 3.8
P2 S PKYSKQNTLKLAT 97.264
P2,10 SG PKYSKQNTLKLGT 373.1615
P2,7,10 SPG PKYSDQNTPKLGT 605.3640
P2,3,7,10 SDPG PKYSDQNTPKLGT 3.1360.07E105
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 386 | DOI: 10.1038/srep00386 2presence of equimolar amount of exchange peptide are shown (the
fractionofHASG/DR1complexremainingovertimeinthepresence
of HASDPG (A), HASG (B) and HA (C) is identified with round
symbols). As evidenced by the different koff values, the rate of
prebound peptide release is a function of the exchange peptide Kd.
In the presence of the exchange peptides a weaker band with slower
electrophoretic mobility is observed (gels below off-rate plots). This
is similar to the L conformer shown in Figures 1 and 2 and will be
temporarily referred to as the pseudo-labile (yL) conformer. Three
distinct observations can be made with regard to the release
experiment shown in Figure 3: 1) the Kd of the exchange peptide is
correlatedtotherateofconversionfromSconformer(identifiedwith
thetriangles)toyL(identifiedwiththesquares),asatanygiventime
the fraction of complexes in S form available depends on the relative
folding abilities of the two peptides
5; 2) the overall loss of band
intensity in each lane at t 5 26 (yL1S) normalized for the
fluorescence intensity at t50, within experimental error and
considering the different techniques adopted, is in keeping with
the fraction of total complex remaining as the labeled peptide is
exchanged (square 1 triangle 5 circle), and 3) the S/yL ratio at t
526 his6:1,5:1and3.5:1inthereactionscontainingSDPG,SGand
HA respectively.
The conformer generated by the exchange peptide is DM-labile.
Next, we determined 1) the stability of the conformer generated by
theadditionoftheexchangepeptide,2)whetherthekineticbehavior
of this specific conformer is a function of the nature of the exchange
peptide by which it was generated, 3) whether the yL band actually
identifies DM-labile complexes, and 4) the relation between the
amount of the yL conformer and the amount of peptide release.
To address these questions, we purified the HASG/DR1 complexes
remaining at the end of the experiment shown in Figure 3 (t 5 26 h)
from free peptide by filtration, and we monitored peptide release in
three new reactions containing 100 nM of purified complexes
(Figure 4A). Conversion between conformers was analyzed by
SDS-PAGE (Figure 4B). At t 5 0, the yL conformer contributes
15.4%, 25.8% and 31.8% of the total amount of complex generated
in the presence of SDPG, SG and HA respectively (Figure 4B and C).
The relative contribution of the yL conformer to the total signal
intensity (yL/(S1yL)) for each reaction in the first portion of this
experiment showed little or no spontaneous release of peptide
(Figure 4C). Therefore, the yL form is relatively stable for at least
12 hours, regardless of the exchange peptide by which it was
generated. At 12 hr we added DM to the reaction and monitored
peptide release. The FP analysis showed a significant release of
peptide (Figure 4A). The gel analysis indicates a loss of the yL
conformer (Figure 4B). The peptide release as the proportion of
the starting concentration is equivalent to the proportion of yL
conformer present in each reaction at the time of DM addition.
This means that all the peptide loss can account for the peptide in
the yL conformer (Figure 4C). These experiments indicate that: 1)
yLformissusceptibletoDMactivity,2)theexchangepeptideactsby
promoting a conformational change of the complex from S to L
Figure 1 | In the absence of exchange peptide, DM functions on a
pMHCII conformer whose concentration is proportional to peptide Kd.
(A) SDS-PAGE analysis of purified peptide/MHCII complexes under
non-reducing conditions. FAM-peptide/DR1 complexes were visualized
by detecting the amount of fluorescence from the bound peptide.
(B) Fraction ofslower migrating form measured as the contribution of the
upper band to total signal intensity for each lane of the gel in panel A is
plotted against peptide Kd. The line indicates the fit to a linear regression.
(C) FP measurement of peptide release in the presence of DM and in the
absence of exchange peptide for the three complexes of panels A–B. Data
areplottedasthefractionofcomplexremainingrelativetot50.Reactions
wereperformedintriplicate,anddatapointsrepresentmean6SDofthree
independent experiments. (D) SDS-PAGE visualization of L (labile) and S
(stabile) conformers before and after peptide release by DM.
www.nature.com/scientificreports
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peptide release.
Discussion
A number of kinetic measurements of peptide dissociation from
pMHCII complexes provide compelling evidence for the existence
of conformational isomers in solution
9,13,14,17. There is evidence that
T-cells can distinguish such conformers
18,19. On electrophoresis gels,
a slower and a faster migrating bands interpreted as evidence for a
‘‘floppy’’ and a ‘‘compact’’ form of pMHCII complexes have been
found for I-A
d1 5 , I-E
k1 6 , I-A
k2 0 , I-A
b2 1and HLA-DR1. Thus, these
two conformers appear to be a general feature of MHCII. These two
conformers cannot be purely gel or detergent artifacts, since the
transition from compact to floppy can be induced in lipid bilayers
22
as well as in buffer in the absence of surfactant
17. The slower migrat-
ing conformation has been indicated as an intermediate in the dis-
sociationoffastermigratingformintoseparateaandbchains
17.The
slower migrating conformer also constitutes a folding interme-
diate in the assembly of a and b chains with the peptide to form
stabile conformer
16. More importantly, a
19F-NMR analysis of the
PCC97–103/I-E
kcomplexrevealedthattheconformational isomerism
is located in the N-terminal part of the complex
13. Indeed, this is the
area with the greatest flexibility, in particular for the DRa chain, as
indicated by higher B-factors in crystal structure and by molecular
dynamic simulations
23.
Here we show that generating pMHCII complexes in a standard
overnight binding reaction with excess peptide results in two con-
formers. The slower migrating band is DM-labile (L). We use the
DM-lability of the slower migrating complex to enrich for the faster
migrating, DM-stable (S) conformer. We show that the S conformer
is stable in the presence of DM, until an exchange peptide is added.
Incubation of a purified S conformer with different exchange pep-
tides in the absence of DM results in the formation of a conformer
withanelectrophoreticmobilitysimilartoL.Interestingly,theextent
of generation of this L-like conformer is a function of the exchange
peptideKd.Finally,ifthe inducedL1Smixispurified awayfromthe
exchange peptide and treated with DM, peptide release is equivalent
to the amount of L conformer. Indeed, SDS-PAGE analysis shows
that this release is correlated with the disappearance of the L con-
former.
We propose that peptide exchange, either in the absence or in the
presence of DM, is mediated through the slower migrating con-
former,whosegeneration isafunctionoftheavailabilityofexchange
peptide. The slower migrating conformer would be structurally dif-
ferent from the faster migrating conformer for a modified geometry
of the binding groove, probably at the level of the a39–a54 region.
Indeed, work based on the analysis of aF54-substituted DR1 mole-
culeshasrecentlyshownthattheinteractionofthecomplexwithDM
is driven by a conformational change of the MHCII protein in the
region of the a-subunit 310 helix and adjacent extended strand
region
24. The L-conformer observed in our experiments may func-
tionallycorrespond to theconformation adoptedbythemutatedDR
in those studies. The above conformational modification may pro-
mote a weakening of the H-bond network at the N-terminal of the
complex and, depending on the distributed binding energy of the
complex, trigger an initial DM-independent release of the peptide,
leaving the P1 pocket emptied. The rearranged complex would fea-
ture a higher affinity for DM than the faster migrating conformer
and would be susceptible to DM activity. As evidenced by a lack of
Figure 2 | DM promotes release of peptides from the S form of the
complex only in the presence of an exchange peptide. (A) FP analysis of
peptide release was carried out in three phases. In phase I, purified FAM-
HASG/DR1complexeswereco-incubatedwith3foldexcessDMandinthe
absence of exchange peptide until reaction steady state was reached. Then
DM was removed on an anti-FLAG column and free peptide by filtration
though centrifugal filter device. Re-purified complexes were then co-
incubated with DM (phase II) for 4 hours in the absence of exchange
peptide, followed by addition of unlabeled HASG in equimolar amount as
compared to complex concentration (phase III). Data are plotted as the
fraction ofcomplex remaining relative to t 5 0.Reactions were performed
in triplicate, and data points represent mean 6 SD of three independent
experiments. (B) – (C) SDS-PAGE gel analysis (B) and relative
quantitation(C)ofsamplesatthebeginningandendofphaseI(lane1and
2), and at the beginning and end of phase II (lane 3 and 4). L, DM labile
conformer; S, DM-stabile conformer.
www.nature.com/scientificreports
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moteadramaticstructuralchangeinthepMHCIIcomplexthatdoes
not follow the usual energetic pathway of peptide/MHCII unfold-
ing
3,4. One possibility is that DM may promote a transient but cata-
strophic destabilization of the pre-bound peptide/MHCII complex,
for instance through exposure of the N-terminal region to solvent.
This destabilization may then be transmitted rapidly throughout the
entire length of the peptide binding groove such that the typical
peptide/MHCII unfolding is absent
5. Under these conditions of
widespread disruption of peptide/MHCII interactions, the probabil-
ity of close proximity of the prebound and exchange peptides to a
destabilized binding groove is enhanced. At this point the exchange
peptide could be tested by the MHCII based on the ability to fold
itself and the groove back into a stable conformation. The prebound
peptide remains loosely tethered to the MHCII and would be able to
rebind if the exchange peptide did not succeed in forming a closed,
low-energy complex. We think that it is very unlikely that with DM
still interacting with the MHCII, the exchange (or the prebound)
peptide would (re)bind in an L-conformer. Rather, DM would be
released from the complex once this assumes an S-conformer. The
possibility of DM affecting both pre-bound peptide release as well as
refolding of the complex around the best fitting peptide is intriguing
and would agree with the evidence that DM ‘‘rescues’’ misfolded DR
from aggregation
25,26. However we do not currently have evidence
supporting this double function for DM.
Recently,anothermodelhasbeenputforwardbasedonDMbind-
ing of HLA-DR2 variants, indicating that DM binds specifically DR
molecules in which the P1 interaction and the surrounding H-bond
network have been destabilized due to system vibration
11. We hypo-
thesize that the aF54-substituted DR1 complexes, the partially emp-
tied MHCII molecule, and our L-conformers are functionally
equivalent. However, if system vibration were the unique reason
for the formation of DM-labile conformers, we should expect spon-
taneous conversion of S into L conformer also in the absence of an
exchange peptide. We could not detect such a conversion for the
lengthofourobservation.Formally,thiscouldbeexplainedpostulat-
ing bidirectional interconversion ( ) with k1 5 k21. However,
the absence of peptide release from isolated S form of the complex in
thepresenceofDMandabsenceofanexchangepeptidesupportsthe
hypothesis that the half-life of the L conformer is $ 12 hours. Our
observationisconsistentwithexperimentsshowingadisproportion-
atestability of theH-bonds surrounding theP1 pocket
24.Theimpact
of the DR2 studies remains, in that they help identify, among all the
possible scenarios, the direction of the peptide exchange reaction,
with the prebound peptide releasing from the N-terminal and the
exchange peptide attempting to bind starting from the P1 region.
We propose that the exchange peptide-induced conformer also
constitutes the structural intermediate for peptide exchange in the
absence of DM. The rate of accumulation of the yL conformer is
proportional to the affinity of the exchange peptide. Indeed, in the
Figure 3 | Presence of exchange peptide promotes conversion from S to
yL conformer. Dissociation of FAM-HASG peptide from DR1 in the
presenceofunlabeledHASDPG(panelA),HASG(B)andHA(C).Peptide
off-rate measured by FP is indicated with the circles.. Data is plotted as
the fraction of complex remaining relative to t 5 0. Below the peptide
release plot, an SDS-PAGE is shown, monitoring the amount of S
conformer of the HASG/DR1 complex over time and conversion to yL
conformer upon incubation with the respective exchange peptide. The
quantitation of the S (m) and yL( &) conformers is reported in the same
graph as the peptide off-rate, and data are plotted as the fraction of
complex in that conformer relative to the S conformer measured at t 5 0.
Reactions were performed in triplicate, and data points represent mean 6
SD of three independent experiments. Lines fit the data to a single or
double exponential decay function.
www.nature.com/scientificreports
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ofHASG/DR1complexfromStoyLreachessteadystateatanearlier
time point as compared to HA. We think that this phenomenon is
related to the ability of an unlabeled exchange peptide with a higher
affinity than the prebound FAM-peptide ( Kd,p , Kd,p* ) to replace
thelatterintheyLconformer. Onthecontrary,anexchangepeptide
withaloweraffinity thantheprebound peptide(Kd,p. Kd,p*)would
still be able to generate yL conformers, but the ability to exchange is
limited. As a consequence, yL conformers containing prebound
(fluorescent) peptide would accumulate at a faster rate (Scheme 1):
This process would be a DM-independent ‘‘compare-exchange’’
routine
5,inwhichpeptideexchangeisacooperativeprocessbasedon
the pre-bound peptide unfolding and the exchange peptide folding
itself and the binding groove. A possible role for a two-peptide inter-
mediate during peptide exchange in the absence of DM has been
suggested by several groups in the past
7,8.
The outcome of DM-mediated peptide exchange could be differ-
ent from the intrinsic exchange depending on whether during
intrinsic exchange the exchange peptide could bind both an L and
S-conformer (‘‘Xp’’ complex in Scheme 1). As shown here, DM
would ignore the complex when it assumes an S conformer and
would only exchange from the L conformer. In other words, DM
would increase the fraction of S conformers at any point in time as
compared to an intrinsic reaction. If intrinsic exchange also only
happens on the L conformer, as we think likely, then the two modes
of peptide exchange are equivalent; with DM acting as a catalyst of
the intrinsic exchange by accelerating the release of the prebound
peptide.
The observation of a subset of DM-labile conformers in the
absence of any exchange peptide is the result of a standard pep-
tide-binding assay in which the excess peptide acts as exchange
peptideandthusinducestheL-conformerinconcentrationspropor-
tional to peptide Kd. While we donot have formal proof that that the
L-conformer generated during a peptide binding step and that gen-
erated by adding peptide to the S-conformer are structurally ident-
ical, they appear to be functionally the same. However, we are
currently in the process of isolating the different complexes gener-
ated in different conditions to further defining the nature of the L-
conformer and provide a more refined mechanism of DM mediated
peptide exchange.
Thebiologicalrelevanceofourdataisthattheyindicatethemech-
anism by which peptides available for loading into MHCII can
induce a conformational state of the pMHCII complex which, in
turn, is amenable to DM-mediated peptide exchange. Because the
exchange is a function of the peptide Kd and occurs as a simple
pairwise comparison, the outcome is the loading of peptides based
on Kd. The rapidity of the exchange allows for establishing an equi-
libriumrepresentation ofthe peptides available inthe endosome as a
functionoftheiraffinity.Thismechanismguaranteesthatevensome
low-affinitypeptidescanbemaintainedintheDM-stableconformer.
This conformer would inform the epitope selection machinery that
the complexes can be shifted to the membrane and represent the
available peptide repertoire as possible TCR ligands.
Methods
Peptide Synthesis. Peptides derived from the sequence GPKYVKQNTLKLAT,
representing residues 306–319 of the hemagglutinin protein from influenza A virus
Figure 4 | The conformer generated in the presence of the exchange
peptide is DM-labile. (A) Release of peptide from HASG/DR1 complexes
isolated at the end of the experiment shown in Figure 3 after purification
fromfreepeptidewasmonitoredbyFP.Thenatureoftheexchangepeptide
present in reaction before purification is indicated in the legend. Data are
plotted as the fraction of complex remaining relative to t 5 0. Reactions
wereperformedintriplicate,anddatapointsrepresentmean6SDofthree
independent experiments. The addition of DM to the three reactions is
indicated.(B)LandSconformersofthecomplexbeforeandafteraddition
of DM were quantitated by SDS PAGE gel. The exchange peptide with
whichthecomplexwasincubatedpriorpurificationisindicatedontheleft.
(C) Modification of the yL/S ratio analyzed by SDS-PAGE gel as shown in
panel B. The nature of the exchange peptide present in reaction before
purification is indicated in the legend. Data are plotted as contribution
from the yL band to total signal intensity in each lane.
www.nature.com/scientificreports
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chains in the HA peptide are numbered relative to the P1 Tyr residue
27. N-terminal
labeling with FAM (Molecular Probes) or LC-LC biotin (Pierce) was performed on
the resin before deprotection, and then peptides were cleaved and purified by HPLC
and confirmed by MALDI-TOF mass spectrometry (Protein Nucleic Acid Shared
Facility – Medical College of Wisconsin).
Expression and Purification of Recombinant Soluble DR1 and DM Protein.
Recombinant soluble empty (peptide free) DR1 was produced and immunoaffinity
purified from a stably transfected Drosophila S2 insect cell line essentially as
described
27. It is known that DR1 produced in S2 cells might have insect-derived
peptide loosely bound once purified. Whether the majority of purified dimers are
‘‘empty’’ DR has been questioned
28. However, it has been shown that the binding
properties of insect cell-derived MHCII molecules are comparable to the binding
properties of a and b chains expressed in E. Coli and then refolded
29. Soluble FLAG
epitope tagged DM was isolated from a stably transfected Drosophila S2 cell line as
described
30. To avoid contamination with FLAG peptide, DM elution from the resin
was performed with 0.1 M glycine HCl, pH 3.5. Both DR1 and DM proteins were
purified and buffer exchanged into PBS (7 mM Na
1/K
1 phosphate, 135 mM NaCl,
pH7.4)using centrifugalultra-filtration(Amicon). Purity(.95%)wasconfirmedby
SDS-PAGE stained withGelCode BlueStainReagent(Pierce).DR1 and DMproteins
were quantified by measuring the UV absorbance @ 280 nm using an E280 of
56340 M
21 cm
21 before use.
Competitive Peptide Binding Assay. Toassess peptideaffinity values, DR1 (20 nm)
was incubated with 20 nm biotinylated HA peptide in PBS (0.1% BSA, 0.01% Tween
20, 0.1 mg/ml 4-(2-aminoethyl)-benzene sulfonyl fluoride, 0.1 mM iodoacetamide,
5 mM EDTA, 0.02% NaN3, pH 7.2) in the presence of varying amounts of inhibitor
peptides at 37 C. Bound biotinylated peptide was detected using a solid-phase
immunoassay and Eu
21 labeled streptavidin. Plates were read using a Wallac
VICTOR counter (PerkinElmer Wallac). Data were fit to a logistic equation y 5 a/
[11(x/x0)
b]. IC50 values were obtained from the curve fit of the binding data and
convertedtoKdvaluesbyusingtheCheng-PrusoffequationKd5(IC50)/(11[bHA]/
Kd,bHA)inwhichKd,bHAwassetequalto14 nMonthebasisoftheresultsofthedirect
binding of bio-HA peptide to DR1. Each point represents the mean and SD of three
independent experiments performed in quadruplicate. Because pMHCII binding
represents a multistep reaction, the IC50 for a competitive binding assay may not be
directlyproportionaltotheKd.Whilethiscanbeoffsetbylongincubationsrelativeto
half-life, we study low-affinity peptides where half-lives are impossible to determine.
Therefore, the values of affinity reported herein should be considered as apparent Kd
values.
Formation of peptide/DR1 complexes. DR1/peptide complexes were formed by
incubating 1 mM DR1 protein with a 10-fold molar excess of FAM-labeled peptidein
50 mM NaH2PO4 and 50 mM of sodium citrate (pH 5.3) and protease inhibitors for
16 h @ 37uC. DR1/peptide complexes were then purified from unbound peptide by
buffer exchange into PBS with a Centricon-30 spin filter that had been pre-incubated
with25 mMMES(pH6.5).PurifiedDR1/peptidecomplexes werethenquantifiedby
reading the UV absorbance @ 280 nm, factoring in an E280 of 1280 M
21 cm
21 for the
Tyr residue and 10846 M
21 cm
21 for the fluorescein present in the bound peptide.
Fluorescence Polarization Dissociation Measurements. 100 nM of purified DR1/
peptide complexes were incubated with or without equimolar unlabeled exchange
peptide and in the presence or in the absence of 3-fold excess DM, depending on the
experimentalconditionsasindicatedinResults.Reactionswereperformedat37uCin
50 mMsodiumcitrate/sodiumphosphatebufferatpH5.0–5.3andwerecoveredwith
mineral oil to prevent evaporation. To avoid non-specific adherence of the protein,
blackpolystyrene96-wellplateswereused(Corning).Measurementswereperformed
using a Wallac VICTOR counter (PerkinElmer Wallac) with the excitation
wavelength 5 485 nm and emission wavelength 5 535 nm. Specific control groups
included (a) protein only, (b) peptide only, and (c) buffer only, and were used for
background correction. FP and anisotropy are mathematically related ways of
expressing parallel:perpendicular emission ratios and are easily interconverted.
Although FP is approximately linear with respect to the ratio of free:bound peptide,
FP was converted to anisotropy (which is exactly linear) by the following equation A
5 2*FP/(3-FP) where A is anisotropy and FP indicates fluorescence polarization in
mP units. Anisotropy values were fitted either according to a single- or a bi-
exponential decay model. Each experiment was performed in triplicate, and the
reported dissociation rate reflects the mean 6 SD of three independent experiments.
SDS-PAGE analysis of DM Mediated and Intrinsic Peptide Dissociation. At
varioustimepoints,aliquotsofthereactionanalyzedbyFP(15 ml)wereremovedand
quenched with 0.5 M Tris-HCl (pH 8.0) in gel loading buffer (SDS 2%, glycerol 10%,
b-mercaptoethanol1%,EDTA12.5 mM,bromophenolblue0.02%)andimmediately
placed on ice. The aliquots were then loaded onto a non-reducing 5%-stacking/12%-
running SDS-PAGE gel without prior sample boiling, and quickly separated by
electrophoresis at 150 V for 30 min. FAM-peptide/DR1 complexes were then
visualized using a Typhoon Trio (GE Healthcare Life Sciences) by measuring the
amount of fluorescence from the bound peptide (excitation wavelength 488 nm,
emission535 nm)andanalyzedwithImageQuantTLsoftware.Eachexperimentwas
performed in triplicate, and the reported dissociation rate reflects the mean6SD of
three independent experiments.
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